Apple Watch Series 12 and Ultra 4 Get Blood Pressure Monitoring — Finally

Apple has been promising blood pressure monitoring on the Apple Watch for years. According to new reports, the Series 12 and Ultra 4 will finally deliver this fall — and the timing is almost too perfect.

What’s actually coming

Blood pressure monitoring has been Apple’s white whale since at least 2018. The new implementation reportedly uses a combination of pulse transit time measurement and optical sensors already present in current models, enhanced with new calibration algorithms developed over the past two years. Unlike Samsung’s approach, Apple’s system will allegedly work without a traditional cuff calibration, though accuracy claims remain unverified until FDA clearance announcements.

Why the timing matters more than the tech

Samsung’s Galaxy Watch 8 launched last month with antioxidant level monitoring — a feature that’s already facing accuracy concerns from health professionals. Apple stepping in with blood pressure, a clinically established vital sign with clear medical utility, positions them as the serious health platform while Samsung chases headline-grabbing novelty features.

The regulatory reality

Blood pressure monitoring requires FDA clearance as a Class II medical device. Apple has reportedly been in discussions with regulators since early 2025, but clearance timing remains the wildcard. The feature may launch as “wellness” tracking initially — showing trends rather than clinical readings — before full medical-grade approval arrives. This is the same path Apple took with AFib detection, and it worked.

What this means for the lineup

The Series 12 is expected to keep the $399 starting price, with the Ultra 4 holding at $799. If blood pressure monitoring lands as a headline feature exclusive to these new models, Apple has a genuine reason for upgrading that isn’t just processor speed or a slightly brighter display. For the 30+ million Americans with undiagnosed hypertension, continuous monitoring on a device they already wear could be genuinely useful.

The bigger picture

Apple’s health ambitions have always been about building a platform, not shipping features. Blood pressure joins blood oxygen, heart rhythm, temperature, and sleep tracking in what’s becoming a comprehensive vital signs dashboard. The question isn’t whether Apple can measure blood pressure — it’s whether they can make the data actionable without turning every user into a hypochondriac.

I’ve been skeptical of wearable health features that promise clinical utility but deliver anxiety. But blood pressure is different. It’s a number people understand, doctors trust, and insurance companies care about. If Apple nails the accuracy — and that’s still a big if — this is the first Apple Watch feature in years that could genuinely change health outcomes rather than just generate notification noise.

The Series 12 announcement is expected at Apple’s September event. I’ll have hands-on impressions as soon as units ship, with particular attention to how the blood pressure readings compare to a traditional cuff. That comparison will tell us everything about whether this is a breakthrough or just another spec sheet bullet point.